SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurocrine Biosciences (NBIX)
NBIX 143.53-1.2%Dec 29 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Miljenko Zuanic who wrote (373)12/23/1999 10:51:00 PM
From: scaram(o)uche  Read Replies (1) of 1834
 
First, let me reiterate..... good timing, fine price, great strategy, job well done Lyons et al.

I was joking, saying it must be a tough job, convincing people to buy NBIX at a 20% discount. That's like marking down a Lamborghini that's already priced like a Ford. Please reread my post from that stance.

But.... you're saying that we should be happy at the end of the food chain? That we should take the scraps thrown at us and be happy for the opportunity?

That's not correct. We should pick and choose among their offerings, and drive them, with our analysis, when and where we want. Do you think it's coincidence that our stocks suddenly get coverage after we add them to a portfolio or start to flesh out a thread? Many of the best scientist-investors in the world, with you leading the pack for '99, contribute to SIB on a regular basis. We are widely followed.

You noticed, Mike, that SIB digs out a good number of leveraged bargains. I would add that many of us avoid most the sudden decompressions at a better than average ratio.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext